129 related articles for article (PubMed ID: 38007092)
1. Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Robin C; Cordonnier C; Tridello G; Knelange N; Xhaard A; Chantepie S; Tanguy-Schmidt A; Schouten HC; Yeshurun M; Rocha V; Srour M; Kröger N; Ledoux MP; Dalgaard J; Thiebaut A; Giardino S; Calore E; Zuckerman T; Groll AH; Raida L; Avcin S; Vicent MG; Kaare A; Drozd-Sokolowska J; Turlure P; Bretagne S; Mikulska M; Camara R; Cesaro S; Styczynski J
Transplant Cell Ther; 2024 Feb; 30(2):235.e1-235.e10. PubMed ID: 38007092
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Ortí G; Gras L; Zinger N; Finazzi MC; Sockel K; Robin M; Forcade E; Avenoso D; Kröger N; Finke J; Radujkovic A; Hunault-Berger M; Schroyens W; Zuckerman T; Bourhis JH; Chalandon Y; Bloor A; Schots R; de Wreede LC; Drozd-Sokolowska J; Raj K; Polverelli N; Czerw T; Hernández-Boluda JC; McLornan D; Yakoub-Agha I
Am J Hematol; 2023 Apr; 98(4):628-638. PubMed ID: 36606718
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?
Redjoul R; Robin C; Foulet F; Leclerc M; Beckerich F; Cabanne L; di Blasi R; Pautas C; Toma A; Botterel F; Maury S; Cordonnier C
Bone Marrow Transplant; 2019 Jul; 54(7):1082-1088. PubMed ID: 30413810
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
De Greef J; Averbuch D; Tondeur L; Duréault A; Zuckerman T; Roussel X; Robin C; Xhaard A; Pagliuca S; Beguin Y; Botella-Garcia C; Khanna N; Le Bourgeois A; Van Praet J; Ho A; Kröger N; Ducastelle Leprêtre S; Roos-Weil D; Aljurf M; Blijlevens N; Blau IW; Carlson K; Collin M; Ganser A; Villate A; Lakner J; Martin S; Nagler A; Ram R; Torrent A; Stamouli M; Mikulska M; Gil L; Wendel L; Tridello G; Knelange N; de la Camara R; Lortholary O; Fontanet A; Styczynski J; Maertens J; Coussement J; Lebeaux D
J Infect; 2024 Jun; 88(6):106162. PubMed ID: 38663756
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
Averbuch D; de la Camara R; Tridello G; Knelange NS; Bykova TA; Ifversen M; Dobsinska V; Ayas M; Hamidieh AA; Pichler H; Perez-Martinez A; Cesaro S; Sundin M; Badell I; Bader P; Johansson JE; Mirci-Danicar O; Sedlacek P; Paillard C; Gibson B; Lawson S; Kroeger N; Corbacioglu S; Mikulska M; Piñana JL; Styczynski J; Ljungman P
Bone Marrow Transplant; 2023 May; 58(5):558-566. PubMed ID: 36849806
[TBL] [Abstract][Full Text] [Related]
8. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of
Dunbar A; Schauwvlieghe A; Algoe S; van Hellemond JJ; Reynders M; Vandecasteele S; Boelens J; Depuydt P; Rijnders B
Front Cell Infect Microbiol; 2020; 10():224. PubMed ID: 32500040
[No Abstract] [Full Text] [Related]
10. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S
Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768
[TBL] [Abstract][Full Text] [Related]
11. Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
Guru Murthy GS; Kim S; Hu ZH; Estrada-Merly N; Abid MB; Aljurf M; Bacher U; Badawy SM; Beitinjaneh A; Bredeson C; Cahn JY; Cerny J; Diaz Perez MA; Farhadfar N; Gale RP; Ganguly S; Gergis U; Hildebrandt GC; Grunwald MR; Hashmi S; Hossain NM; Kalaycio M; Kamble RT; Kharfan-Dabaja MA; Hamilton BK; Lazarus HM; Liesveld J; Litzow M; Marks DI; Murthy HS; Nathan S; Nazha A; Nishihori T; Patel SS; Pawarode A; Rizzieri D; Savani B; Seo S; Solh M; Ustun C; van der Poel M; Verdonck LF; Vij R; Wirk B; Oran B; Nakamura R; Scott B; Saber W
JAMA Oncol; 2022 Mar; 8(3):404-411. PubMed ID: 35024768
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of Pneumocystis jirovecii Infection and Colonization in Immunocompromised Patients with Pneumonia].
Gülbudak H; Öztürk C; Kuyugöz S; Tezcan Ülger S
Mikrobiyol Bul; 2020 Oct; 54(4):583-595. PubMed ID: 33107287
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of Pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: Cross-sectional study.
Ricci G; Santos DW; Kovacs JA; Nishikaku AS; de Sandes-Freitas TV; Rodrigues AM; Kutty G; Affonso R; Silva HT; Medina-Pestana JO; de Franco MF; Colombo AL
Mycoses; 2018 Nov; 61(11):845-852. PubMed ID: 29992629
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].
Özkoç S; Bayram Delibaş S
Mikrobiyol Bul; 2015 Apr; 49(2):221-30. PubMed ID: 26167822
[TBL] [Abstract][Full Text] [Related]
17. Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
Saito T; Seo S; Kanda Y; Shoji N; Ogasawara T; Murakami J; Tanosaki R; Tobinai K; Takaue Y; Mineishi S
Am J Hematol; 2001 Jul; 67(3):206-9. PubMed ID: 11391721
[TBL] [Abstract][Full Text] [Related]
18. Six-month risk of Pneumocystis pneumonia following acute cellular rejection: A case-control study in solid organ transplant recipients.
Hosseini-Moghaddam SM; Shokoohi M; Singh G; Nagpal AD; Jevnikar AM
Clin Transplant; 2021 Jul; 35(7):e14322. PubMed ID: 33882151
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis.
Andreasen PB; Rezahosseini O; Møller DL; Wareham NE; Thomsen MT; Houmami R; Knudsen AD; Knudsen J; Kurtzhals JAL; Rostved AA; Pedersen CR; Rasmussen A; Nielsen SD
Immun Inflamm Dis; 2022 Jan; 10(1):93-100. PubMed ID: 34713963
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT.
Gilleece MH; Labopin M; Savani BN; Yakoub-Agha I; Socié G; Gedde-Dahl T; Blaise D; Byrne JL; Craddock C; Cornelissen JJ; Arcese W; Forcade E; Crawley C; Polge E; Mohty M; Nagler A
Leukemia; 2020 Jan; 34(1):87-99. PubMed ID: 31363160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
